Table 6.
Maternal cerebral autoregulation data for participants in the exercise and control group at the end of trimester 1, 2 and 3
| Exercise group (N = 7) | Control group (N = 11) | Two-way ANOVA | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Trimester | T1 | T2 | T3 | T1 | T2 | T3 | Time | Intervention | Time × intervention |
| MAP | 99 ± 11 | 98 ± 10 | 98 ± 9 | 101 ± 8 | 98 ± 10 | 98 ± 9 | 0.67 | 0.81 | 0.96 |
| PETCO2 | 32.0 ± 2.8 | 34.7 ± 1.5 | 34.6 ± 1.4 | 33.8 ± 2.0 | 35.0 ± 1.1 | 35.8 ± 0.8 | 0.85 | 0.68 | 0.66 |
| Gain (cm s−1 mmHg−1) | 1.2 ± 0.3 | 1.3 ± 0.3 | 1.0 ± 0.1 | 0.9 ± 0.3 | 1.1 ± 0.3 | 1.0 ± 0.3 | 0.13 | 0.04 | 0.34 |
| Phase (degrees) | 21.1 ± 10.6 | 39.6 ± 8.4 | 34.7 ± 9.1 | 32.9 ± 13.2 | 32.8 ± 12.9 | 47.1 ± 29.4 | 0.06 | 0.26 | 0.10 |
| Normalised gain (%cm s−1% mmHg−1mmHg/%) | 1.6 ± 0.5 | 1.9 ± 0.5 | 1.6 ± 0.3 | 1.3 ± 0.4 | 1.8 ± 0.5 | 1.6 ± 0.4 | 0.08 | 0.22 | 0.71 |
| Coherence | 0.66 ± 0.07 | 0.58 ± 0.16 | 0.62 ± 0.10 | 0.54 ± 0.14 | 0.63 ± 0.09 | 0.61 ± 0.09 | - | - | - |
Values are mean ± SD. Italics represent significant main effect (P < 0.05)
T1 trimester 1, T2 trimester 2, T3 trimester 3